You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
The research network said in a statement that precision breeding techniques are needed to achieve the UN's Sustainable Development Goals.
A European Union budget deal provides less funding than expected for its Horizon Europe research program, according to Science.
The targeted sequencing assay analyzes 12 genes and can be paired with the firm's BRCA gene testing kit.
Nature News reports on policy changes research funding agencies are making to deal with pandemic-related effects on research labs.
Mauro Ferrari discusses his short stay at the European Research Council at ScienceInsider.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.
Nature News notes that Brexit will be followed by months of negotiating, including about scientific research.
Paul Nurse, the director of the Francis Crick Institute, says British science will suffer if the UK isn't part of Horizon Europe funding scheme, according to the Guardian.
EASI-Genomics was launched earlier this year to provide free access to NGS technologies and genomic services to researchers from industry and academia.
The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.
A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.
NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.
In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.